The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Gene Expression Omnibus: NCBI gene expression and hybridization array data repository
Edgar, R. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.207 · Cited by 13,288
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues
Swerdlow, S. H. (2017) · Medical Entomology and Zoology · Cited by 12,933
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
Irizarry, R. A. (2003) · Biostatistics · doi:10.1093/biostatistics/4.2.249 · Cited by 10,603
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
The Cancer Genome Atlas Research Network (2008) · Nature · doi:10.1038/nature07385 · Cited by 7,735
International scoring system for evaluating prognosis in myelodysplastic syndromes
Greenberg, P., Cox, C., LeBeau, M. M., Fenaux, P., Morel, P., Sanz, G., Sanz, M., Vallespi, T., Hamblin, T., Oscier, D., et al. (1997) · Blood · doi:10.1182/blood.v89.6.2079 · Cited by 4,427
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
Jones, S., Zhang, X., Parsons, D. W., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Kamiyama, H., Jimeno, A., et al. (2008) · Science · doi:10.1126/science.1164368 · Cited by 3,969
WHO classification of haematolymphoid tumours
Gaillard, F., Weerakkody, Y., & Sharma, R. (2010) · Radiopaedia.org · doi:10.53347/rid-9250 · Cited by 3,776
Proposals for the classification of the myelodysplastic syndromes
Bennett, J. M., Catovsky, D., Daniel, M. T., Flandrin, G., Galton, D. A. G., Gralnick, H. R., & Sultan, C. (1982) · British Journal of Haematology · doi:10.1111/j.1365-2141.1982.tb08475.x · Cited by 3,627
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
Bartkova, J., Hořejší, Z., Koed, K., Krämer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J. M., Lukas, C., et al. (2005) · Nature · doi:10.1038/nature03482 · Cited by 2,688
Fenaux, P., Mufti, G. J., Hellstrom-Lindberg, E., Santini, V., Finelli, C., Giagounidis, A., Schoch, R., Gattermann, N., Sanz, G., List, A., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70003-8 · Cited by 2,663
Self-citationThe JNK signal transduction pathway
Weston, C. (2002) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(01)00258-1 · Cited by 1,528
Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML
Jamieson, C. H. M., Ailles, L. E., Dylla, S. J., Muijtjens, M., Jones, C., Zehnder, J. L., Gotlib, J., Li, K., Manz, M. G., Keating, A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040258 · Cited by 1,485
Lenalidomide in the Myelodysplastic Syndrome with Chromosome 5q Deletion
List, A., Dewald, G., Bennett, J., Giagounidis, A., Raza, A., Feldman, E., Powell, B., Greenberg, P., Thomas, D., Stone, R., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061292 · Cited by 1,319
Self-citationThe JNK signal transduction pathway
Weston, C. R., & Davis, R. J. (2007) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2007.02.001 · Cited by 1,021
Molecular views of recombination proteins and their control
West, S. C. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1127 · Cited by 956
Harris, N. L., Jaffe, E. S., Diebold, J., Flandrin, G., Muller-Hermelink, H. K., Vardiman, J., Lister, T. A., & Bloomfield, C. D. (1999) · Annals of Oncology · doi:10.1023/a:1008375931236 · Cited by 846
Haase, D., Germing, U., Schanz, J., Pfeilstöcker, M., Nösslinger, T., Hildebrandt, B., Kundgen, A., Lübbert, M., Kunzmann, R., Giagounidis, A. A. N., et al. (2007) · Blood · doi:10.1182/blood-2007-03-082404 · Cited by 794
Self-citationAcquired mutations in TET2 are common in myelodysplastic syndromes
Langemeijer, S. M. C., Kuiper, R. P., Berends, M., Knops, R., Aslanyan, M. G., Massop, M., Stevens-Linders, E., van Hoogen, P., van Kessel, A. G., Raymakers, R. A. P., et al. (2009) · Nature Genetics · doi:10.1038/ng.391 · Cited by 680
Zhao, H., Watkins, J. L., & Piwnica-Worms, H. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182557299 · Cited by 461
Distinct haematological disorder with deletion of long arm of No. 5 chromosome
VAN DEN BERGHE, H., CASSIMAN, J.-J., DAVID, G., FRYNS, J.-P., MICHAUX, J.-L., & SOKAL, G. (1974) · Nature · doi:10.1038/251437a0 · Cited by 442
Heaney, M. L., & Golde, D. W. (1999) · New England Journal of Medicine · doi:10.1056/nejm199905273402107 · Cited by 388
Parker, J. E., Mufti, G. J., Rasool, F., Mijovic, A., Devereux, S., & Pagliuca, A. (2000) · Blood · doi:10.1182/blood.v96.12.3932 · Cited by 363
Thrombopoietin, the Mp1 ligand, is essential for full megakaryocyte development.
Kaushansky, K., Broudy, V. C., Lin, N., Jorgensen, M. J., McCarty, J., Fox, N., Zucker-Franklin, D., & Lofton-Day, C. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.8.3234 · Cited by 313
Dysregulated gene expression networks in human acute myelogenous leukemia stem cells
Majeti, R., Becker, M. W., Tian, Q., Lee, T.-L. M., Yan, X., Liu, R., Chiang, J.-H., Hood, L., Clarke, M. F., & Weissman, I. L. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900089106 · Cited by 281
Hutchinson, J., Jin, J., Cardiff, R. D., Woodgett, J. R., & Muller, W. J. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.6.2203-2212.2001 · Cited by 280
Kitagawa, M., Saito, I., Kuwata, T., Yoshida, S., Yamaguchi, S., Takahashi, M., Tanizawa, T., Kamiyama, R., & Hirokawa, K. (1997) · Leukemia · doi:10.1038/sj.leu.2400844 · Cited by 254
Distinct clinical outcomes for cytogenetic abnormalities evolving from aplastic anemia
Maciejewski, J. P., Risitano, A., Sloand, E. M., Nunez, O., & Young, N. S. (2002) · Blood · doi:10.1182/blood.v99.9.3129 · Cited by 252
Chk1 is haploinsufficient for multiple functions critical to tumor suppression
Lam, M. H., Liu, Q., Elledge, S. J., & Rosen, J. M. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.015 · Cited by 247
Boultwood, J., Lewis, S., & Wainscoat, J. (1994) · Blood · doi:10.1182/blood.v84.10.3253.3253 · Cited by 246
Self-citationPellagatti, A. (2006) · Blood · doi:10.1182/blood-2005-12-4769 · Cited by 209
Self-citationPlk4 haploinsufficiency causes mitotic infidelity and carcinogenesis
Ko, M. A., Rosario, C. O., Hudson, J. W., Kulkarni, S., Pollett, A., Dennis, J. W., & Swallow, C. J. (2005) · Nature Genetics · doi:10.1038/ng1605 · Cited by 204
Dominguez, I., Sonenshein, G. E., & Seldin, D. C. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-9153-z · Cited by 201
Altered oncoprotein expression and apoptosis in myelodysplastic syndrome marrow cells
Rajapaksa, R., Ginzton, N., Rott, L., & Greenberg, P. (1996) · Blood · doi:10.1182/blood.v88.11.4275.4275 · Cited by 192
Chen, G., Zeng, W., Miyazato, A., Billings, E., Maciejewski, J. P., Kajigaya, S., Sloand, E. M., & Young, N. S. (2004) · Blood · doi:10.1182/blood-2004-01-0103 · Cited by 172
Gene expression profiling of CD34+ cells in patients with the 5q− syndrome
Boultwood, J., Pellagatti, A., Cattan, H., Lawrie, C. H., Giagounidis, A. A. N., Malcovati, L., Porta, M. G. D., Jädersten, M., Killick, S. B., Fidler, C., et al. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06833.x · Cited by 167
Self-citationFanconi anaemia and leukaemia – clinical and molecular aspects
Tischkowitz, M., & Dokal, I. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05023.x · Cited by 165
Repression of RAD51 gene expression by E2F4/p130 complexes in hypoxia
Bindra, R. S., & Glazer, P. M. (2007) · Oncogene · doi:10.1038/sj.onc.1210001 · Cited by 161
Fas/Apo-1(CD95) expression and apoptosis in patients with myelodysplastic syndromes
Bouscary, D., De Vos, J., Guesnu, M., Jondeau, K., Viguier, F., Melle, J., Picard, F., Dreyfus, F., & Fontenay-Roupie, M. (1997) · Leukemia · doi:10.1038/sj.leu.2400654 · Cited by 159
Greenberg, P. L., Young, N. S., & Gattermann, N. (2002) · Hematology · doi:10.1182/asheducation-2002.1.136 · Cited by 153
The myelodysplastic syndrome(s): a perspective and review highlighting current controversies
Steensma, D. P., & Tefferi, A. (2003) · Leukemia Research · doi:10.1016/s0145-2126(02)00098-x · Cited by 152
Evidence for reduced B-cell progenitors in early (low-risk) myelodysplastic syndrome
Sternberg, A. J., Killick, S., Littlewood, T., Hatton, C., Peniket, A., Seidl, T., Soneji, S., Leach, J., Bowen, D., Chapman, C., et al. (2005) · Blood · doi:10.1182/blood-2005-04-1543 · Cited by 150
Self-citationKotsianidis, Ι., Bouchliou, I., Nakou, E., Spanoudakis, E., Margaritis, D., Christophoridou, A. V., Anastasiades, A., Tsigalou, C., Bourikas, G., Karadimitris, A., et al. (2008) · Leukemia · doi:10.1038/leu.2008.333 · Cited by 147
Ceramide-induced cell death in malignant cells
Carpinteiro, A., Dumitru, C. A., Schenck, M., & Gulbins, E. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.02.020 · Cited by 122
Protective Role for c-Jun in the Cellular Response to DNA Damage
Potapova, O., Basu, S., Mercola, D., & Holbrook, N. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102075200 · Cited by 121
Pathobiology, classification, and diagnosis of myelodysplastic syndrome
Mufti, G. J. (2004) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2004.08.007 · Cited by 119
Pellagatti, A., Hellström‐Lindberg, E., Giagounidis, A. A. N., Perry, J., Malcovati, L., Porta, M. G. D., Jädersten, M., Killick, S. B., Fidler, C., Cazzola, M., et al. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07178.x · Cited by 114
Self-citationChromosome and Molecular Abnormalities in Myelodysplastic Syndromes
Fenaux, P. (2001) · International Journal of Hematology · doi:10.1007/bf02994004 · Cited by 114
Tehranchi, R. (2005) · Blood · doi:10.1182/blood-2004-12-4649 · Cited by 104
IFN-γ Negatively Modulates Self-Renewal of Repopulating Human Hemopoietic Stem Cells
Yang, L., Dybedal, I., Bryder, D., Nilsson, L., Sitnicka, E., Sasaki, Y., & Jacobsen, S. E. W. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.2.752 · Cited by 104
Prognostic factors and scoring systems in myelodysplastic syndromes.
Sanz, G. F., Sanz, M. Á., & Greenberg, P. L. (1998) · PubMed · Cited by 102
Aberrant Function of the Ras-Related Protein TC21/R-Ras2 Triggers Malignant Transformation
Graham, S. M., Cox, A. D., Drivas, G., Rush, M. G., D’Eustachio, P., & Der, C. J. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.6.4108-4115.1994 · Cited by 97
Multiple members of the TNF superfamily contribute to IFN-γ-mediated inhibition of erythropoiesis
Felli, N., Pedini, F., Zeuner, A., Petrucci, E., Testa, U., Conticello, C., Biffoni, M., Di Cataldo, A., Winkles, J. A., Peschle, C., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.3.1464 · Cited by 96
Sloand, E. M., Kim, S., Führer, M., Risitano, A. M., Nakamura, R., Maciejewski, J. P., Barrett, A. J., & Young, N. S. (2002) · Blood · doi:10.1182/blood-2002-01-0096 · Cited by 96
The cytogenetics of myelodysplastic syndromes
Olney, H. J., & Beau, M. M. L. (2001) · Best Practice & Research Clinical Haematology · doi:10.1053/beha.2001.0151 · Cited by 89
Clark, G. J., Kinch, M. S., Gilmer, T. M., Burridge, K., & Der, C. J. (1996) · PubMed · Cited by 88
Giagounidis, A. A. N., & Aul, C. (2007) · Springer eBooks · doi:10.1007/978-0-387-73744-7_6 · Cited by 74
Self-citationMyelodysplastic syndromes: biology and treatment
Jädersten, M., & Hellström‐Lindberg, E. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2008.02052.x · Cited by 73
Self-citationTherapeutic Potential of “Rexinoids” in Cancer Prevention and Treatment
Tanaka, T., & Luca, L. M. D. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4407 · Cited by 72
The Role of the Immune System in Myelodysplasia: Implications for Therapy
Sloand, E. M., & Rezvani, K. (2008) · Seminars in Hematology · doi:10.1053/j.seminhematol.2007.11.006 · Cited by 64
Suppression of the DNA damage response in acute myeloid leukemia versus myelodysplastic syndrome
Boehrer, S., Adès, L., Tajeddine, N., Hofmann, W.-K., Kriener, S., Bug, G., Ottmann, O. G., Ruthardt, M., Galluzzi, L., Fouassier, C., et al. (2009) · Oncogene · doi:10.1038/onc.2009.69 · Cited by 63
Genetic Testing in the Myelodysplastic Syndromes: Molecular Insights Into Hematologic Diversity
Steensma, D. P., & List, A. F. (2005) · Mayo Clinic Proceedings · doi:10.4065/80.5.681 · Cited by 59
Insights into signaling and function of hematopoietic stem cells at the single-cell level
Yamazaki, S., & Nakauchi, H. (2009) · Current Opinion in Hematology · doi:10.1097/moh.0b013e32832c6705 · Cited by 26
Characterization of defective megakaryocytic development in patients with myelodysplastic syndromes
Hofmann, W., Kalina, U., Wagner, S., Seipelt, G., Ries, C., Hoelzer, D. F., & Ottmann, O. G. (1999) · Experimental Hematology · doi:10.1016/s0301-472x(98)00077-0 · Cited by 24
Cited by
Somatic SF3B1 Mutation in Myelodysplasia with Ring Sideroblasts
Papaemmanuil, E., Cazzola, M., Boultwood, J., Malcovati, L., Vyas, P., Bowen, D., Pellagatti, A., Wainscoat, J. S., Hellstrom-Lindberg, E., Gambacorti-Passerini, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103283 · Cited by 1,222
Self-citationXist RNA Is a Potent Suppressor of Hematologic Cancer in Mice
Yildirim, E., Kirby, J. E., Brown, D. E., Mercier, F. E., Sadreyev, R. I., Scadden, D. T., & Lee, J. T. (2013) · Cell · doi:10.1016/j.cell.2013.01.034 · Cited by 522
The NLRP3 inflammasome functions as a driver of the myelodysplastic syndrome phenotype
Basiorka, A. A., McGraw, K. L., Eksioglu, E. A., Chen, X., Johnson, J., Zhang, L., Zhang, Q., Irvine, B. A., Cluzeau, T., Sallman, D. A., et al. (2016) · Blood · doi:10.1182/blood-2016-07-730556 · Cited by 348
MLL3 Is a Haploinsufficient 7q Tumor Suppressor in Acute Myeloid Leukemia
Chen, C., Liu, Y., Rappaport, A. R., Kitzing, T., Schultz, N., Zhao, Z., Shroff, A. S., Dickins, R. A., Vakoc, C. R., Bradner, J. E., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.03.016 · Cited by 311
Inflammation-Induced Tumorigenesis and Metastasis
Hibino, S., Kawazoe, T., Kasahara, H., Itoh, S., Ishimoto, T., Sakata-Yanagimoto, M., & Taniguchi, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115421 · Cited by 290
Metadata
- Authors
- Pellagatti, A., Cazzola, M., Giagounidis, A., Perry, J., Malcovati, L., Della Porta, M. G., Jädersten, M., Killick, S., Verma, A., Norbury, C. J., Hellström-Lindberg, E., Wainscoat, J. S., & Boultwood, J.
- Venue
- Leukemia
- Published
- 2010-03-11
- Volume
- 24
- Issue
- 4
- Pages
- 756-764
- ISSN
- 0887-6924 (ISSN-L)
- 1476-5551
- OpenAlex
- W1979882109
- Cited by
- 288
- References
- 64
- FWCI
- 12.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.